CTC enumeration and characterization: moving toward personalized medicine

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Distant metastasization remains the primary cause of breast cancer mortality.
• Standard imaging methods often fail to detect early tumor cell dissemination.
• Circulating tumor cells (CTCs) are emerging as crucial biomarkers.

Purpose of the Study:

• To review current CTC detection strategies and their clinical validity.
• To explore the potential impact of CTC analysis on clinical trial design and practice.
• To highlight the role of CTCs in personalized breast cancer treatment.

Main Methods:

• Review of current literature on CTC detection technologies.
• Analysis of evidence supporting the clinical utility of CTC enumeration.
• Discussion of molecular and genomic characterization of CTCs from liquid biopsies.

Main Results:

• CTC enumeration serves as a prognostic and predictive biomarker.
• CTCs enable early detection of micrometastases and monitoring of therapeutic response.
• Liquid biopsy using CTCs offers a less invasive alternative to tissue biopsies.

Conclusions:

• CTC detection and characterization are vital for monitoring breast cancer progression.
• Molecular analysis of CTCs can guide personalized treatment selection.
• Implementing CTC analysis in clinical practice can enhance decision-making and improve patient care.